Group 1 - The core announcement is that Jin Hai Medical Technology (02225.HK) has signed a capital contribution agreement to increase the registered capital of Jin Hai Biomedical from RMB 5 million to RMB 25 million by February 25, 2026 [1] - Shanghai Jin Hai and Shanghai Anbida Investment will contribute an additional total of RMB 20 million according to their respective equity ratios of 51:49 [1] - As of February 25, 2026, Jin Hai Medical Technology's stock closed at HKD 1.87, down 2.6%, with a trading volume of 3.31 million shares and a turnover of HKD 6.2073 million [1] Group 2 - The company has a market capitalization of HKD 10.157 billion and ranks 8th in the integrated II industry [1] - There has been low attention from investment banks, with no ratings given in the past 90 days [1]
今海医疗科技(02225.HK)附属今海生物医疗拟获2000万元增资